ELVN
ENLIVEN THERP (ELVN)
NASDAQ
$48.59+$2.63 (+5.72%)
Price as of Jun 23, 2026 6:47 PM EDT
  • $3.2B
    Market Cap
  • 126.52%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
ORBIMED ADVISORS LLC
11.40%
8.0M
0 (0.00%)
Mar 31, 2026
FMR LLC
9.78%
6.8M
-278,389 (-4.08%)
Mar 31, 2026
POLAR CAPITAL HOLDINGS PLC
7.25%
5.1M
+1.6M (+30.64%)
Mar 31, 2026
BLACKROCK, INC.
5.28%
3.7M
+71,381 (+1.94%)
Mar 31, 2026
COMMODORE CAPITAL LP
4.69%
3.3M
-1.4M (-43.29%)
Mar 31, 2026
VESTAL POINT CAPITAL, LP
4.65%
3.3M
-580,000 (-17.85%)
Mar 31, 2026
BLACKROCK FUNDING, INC. /DE
4.25%
3.0M
+28,486 (+0.96%)
Dec 31, 2024

Current Ownership Distribution

  • Institutions345.4M (78.45%)
  • Mutual Funds83.9M (19.05%)
  • Insiders11.0M (2.50%)
  • Other0 (0.00%)

Insider Transactions

  • 2.50% (11.0M)
    Current InsiderOwnership (%, shares)
  • 0
    Number of InsiderBuying (last 12 months)
  • $0.00
    Amount of InsiderBuying (last 12 months)
  • 7
    Number of InsiderSelling (last 12 months)
  • $796.0M
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Collins Helen Louise
CHIEF MEDICAL OFFICER
Exempt
Jun 17, 2026
$0.00
5,000
$0.00
121,268
Collins Helen Louise
CHIEF MEDICAL OFFICER
Exempt
Jun 17, 2026
$12,400.00
5,000
$2.48
30,000
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sell
Jun 17, 2026
$54,304.64
1,268
$42.83
28,732
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sell
Jun 17, 2026
$114,018.39
2,599
$43.87
26,133
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sell
Jun 17, 2026
$50,693.82
1,133
$44.74
25,000
ORBIMED ADVISORS LLC
Sell
Jun 15, 2026
$409,051.72
9,086
$45.02
245,728
ORBIMED ADVISORS LLC
Sell
Jun 15, 2026
$12.3M
272,322
$45.02
7.4M
Collins Helen Louise
CHIEF MEDICAL OFFICER
Exempt
Mar 17, 2026
$0.00
5,000
$0.00
176,268
Collins Helen Louise
CHIEF MEDICAL OFFICER
Exempt
Mar 17, 2026
$12,400.00
5,000
$2.48
30,000
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sell
Mar 17, 2026
$138,800.00
5,000
$27.76
25,000
Collins Helen Louise
CHIEF MEDICAL OFFICER
Exempt
Mar 10, 2026
$0.00
10,129
$0.00
181,268
Collins Helen Louise
CHIEF MEDICAL OFFICER
Exempt
Mar 10, 2026
$25,119.92
10,129
$2.48
35,129
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sell
Mar 10, 2026
$305,826.92
10,129
$30.19
25,000
Collins Helen Louise
CHIEF MEDICAL OFFICER
Exempt
Mar 09, 2026
$74,080.08
29,871
$2.48
54,871
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sell
Mar 09, 2026
$896,811.06
29,871
$30.02
25,000
Collins Helen Louise
CHIEF MEDICAL OFFICER
Exempt
Mar 09, 2026
$0.00
29,871
$0.00
191,397
Collins Helen Louise
CHIEF MEDICAL OFFICER
Exempt
Feb 17, 2026
$0.00
45,000
$0.00
221,268
Collins Helen Louise
CHIEF MEDICAL OFFICER
Exempt
Feb 17, 2026
$111,600.00
45,000
$2.48
70,000
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sell
Feb 17, 2026
$1.2M
45,000
$26.17
25,000
Gupta Rishi
Award
Feb 12, 2026
$0.00
33,989
$0.00
33,989
Collins Helen Louise
CHIEF MEDICAL OFFICER
Award
Feb 12, 2026
$0.00
150,000
$0.00
150,000
Derynck Mika K
Award
Feb 12, 2026
$0.00
17,126
$0.00
17,126
Collins Helen Louise
CHIEF MEDICAL OFFICER
Award
Feb 12, 2026
$0.00
25,000
$0.00
25,000
Gupta Rishi
Award
Feb 12, 2026
$0.00
1,580
$0.00
1,580
Ballal Rahul D.
Award
Feb 12, 2026
$0.00
17,126
$0.00
17,126
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
Sell
Feb 06, 2026
$145,219.00
5,000
$29.04
740,188
Heyman Richard A.
Sell
Jan 20, 2026
$13,547.11
512
$26.46
24,595
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
Sell
Jan 20, 2026
$144,814.14
5,491
$26.37
759,697
Heyman Richard A.
Sell
Jan 20, 2026
$19,354.41
718
$26.96
23,877
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
Sell
Jan 20, 2026
$390,284.85
14,509
$26.90
745,188